Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-306
Closed -$206K 75
2025
Q4
$206K Buy
+306
New +$193K 0.1% 73
2025
Q3
Sell
-110,774
Closed -$38.8M 133
2025
Q2
$38.8M Buy
110,774
+59,618
+117% +$19.3M 0.11% 170
2025
Q1
$13.6M Buy
51,156
+28,837
+129% +$9.94M 0.04% 333
2024
Q4
$7.23M Sell
22,319
-12,578
-36% -$3.18M 0.02% 449
2024
Q3
$4.56M Sell
34,897
-19,910
-36% -$1.82M 0.01% 570
2024
Q2
$4.56M Buy
54,807
+13,671
+33% +$1.06M 0.01% 551
2024
Q1
$2.85M Sell
41,136
-114,227
-74% -$6.05M 0.01% 689
2023
Q4
$6.19M Buy
155,363
+126,563
+439% +$4.96M 0.02% 503
2023
Q3
$1.15M Buy
+28,800
New +$1.02M ﹤0.01% 816
2022
Q4
Sell
-11,207
Closed -$218K 1135
2022
Q3
$218K Sell
11,207
-4,850
-30% -$145K ﹤0.01% 1078
2022
Q2
$553K Buy
+16,057
New +$645K ﹤0.01% 957

Other funds holding APP

Axa's APP Position: Q1 2026 in Review

Axa sold out of Applovin (APP) in Q1 2026, closing a stake of 306 shares — an estimated $206K sold.

Axa first reported a position in APP in Q2 2022 and held it in 11 quarters. The position peaked at $38.8M in Q2 2025. 1,390 funds tracked by Wall St. Rank hold APP as of Q1 2026.

  • Axa reported no remaining Applovin position as of Q1 2026 after selling out during the quarter.
  • Axa sold 306 Applovin shares in Q1 2026, an estimated $206K.
  • Axa first reported a position in Applovin in Q2 2022 and held it in 11 quarters.
  • Axa's Applovin position peaked at $38.8M in Q2 2025.
  • 1,390 funds tracked by Wall St. Rank held Applovin as of Q1 2026.

Based on Axa's 13F filing for Q1 2026, filed 15 May 2026.